A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non–Small-Cell Lung Cancer (Q59273983)
Jump to navigation
Jump to search
scientific article published on 19 May 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non–Small-Cell Lung Cancer |
scientific article published on 19 May 2012 |
Statements
A phase Ib, dose-finding study of erlotinib in combination with a fixed dose of pertuzumab in patients with advanced non-small-cell lung cancer (English)
Malcolm Ranson
Susana Cedrés
Mike Brewster
Pablo Martínez
Virginia McNally
Graham Ross
Danny Galdermans